Risk to resilience: a roadmap to vaccine access for older Australians

We have an opportunity to give the Australian health system the shot in the arm it needs, by increasing access to innovative vaccines, particularly for older Australians.

Risk To Resilience
3:03

Risk to Resilience: a roadmap to vaccine access for older Australians

Immunisation saves lives; it helps people of all ages live longer and healthier. Vaccination is recognised as one of the most cost-effective public health interventions. Yet Australia is under-investing in adult vaccination, with the negative impacts clustered in our most disadvantaged communities.

‘Risk to Resilience: a roadmap to vaccine access for older Australians explores the potential to strengthen Australia's NIP to benefit more people. It quantifies the benefits of a National Immunisation Program (NIP) that draws on its previous success by expanding its focus to include providing the latest advances in vaccines for older Australians. 

GSK commissioned Clarivate Life Sciences and Health Care to conduct a detailed analysis, mapping federal electorate divisions by four factors that may make people more vulnerable to preventable disease and subsequent poorer health outcomes: age, income, education and comorbidities. These factors exacerbate barriers to accessing healthcare and technology due to affordability, accessibility and health literacy.

The postcode you live in shouldn't be a predictor of your health. By addressing the underlying barriers to immunisation we can build a stronger, healthier and more resilient Australia for all.
Prof Rob Booy

Professor Robert Booy

Professor of Paediatrics and Child health, University of Sydney

_